Prostate Cancer: From Molecular Imaging to Immunological and Target Therapies

Biomedicines. 2023 Apr 14;11(4):1176. doi: 10.3390/biomedicines11041176.

Abstract

Prostate cancer (PCa) is one of the most common malignancies and a leading cause of cancer-related deaths, affecting a million people worldwide with a particularly high burden in countries with a low human development index [...].

Publication types

  • Editorial